More Articles
Artrya Limited, an Australian healthcare technology company focused on diagnosing coronary artery disease (CAD), has expanded its operations to the United States.
…
COVID-19 patients face a heightened risk of deep vein thrombosis (DVT) for up to three months after their infection, according to a new analysis of more than five million patients published in The BMJ.[1] Researchers also…
ACC.22, the American College of Cardiology’s 71st Annual Scientific Session and Expo, saved some of its biggest late-breaking clinical trials for its final day.
Monday morning’s late-breakers began…
ACC.22, the American College of Cardiology’s 71st Annual Scientific Session & Expo, is underway in Washington, D.C., giving many cardiology professionals their first taste of an in-person conference since the start of the COVID-19…
Patients battling depression after a heart attack may be much more likely to suffer a stroke, according to new research presented at ACC.22, the American College of Cardiology’s 71st Annual Scientific Session.
…
Medtronic has recalled approximately 6,000 IN.PACT Admiral catheters and three IN.PACT AV catheters, the company announced Thursday.
This is a voluntary recall due to potential pouch damage that…
Regularly eating avocados is associated with a reduced risk of cardiovascular disease (CVD), according to new research published in the Journal of the American Heart Association.[1]
The study…
Thrombolysis is an effective alternative to surgery for patients with prosthetic valve thrombosis (PVT), according to new findings published in the Journal of the American College of Cardiology.[1]
…
Researchers that developed a new imaging technique designed to create full 3D visualizations of blood vessels, shared their progress in Nature Methods.[1]
“Usually, if you want to gather data…
Patients with atrial fibrillation (AFib) may be able to reduce their risk of developing dementia by taking direct-acting oral anticoagulants (DOACs) instead of warfarin, according to a new study published in the Journal of the…
Percutaneous coronary intervention (PCI) can improve the odds of survival for certain ischemic heart failure (HF) patients with moderate-to-severe functional mitral regurgitation (FMR), according to new findings published in the …
Treatment with evolocumab (Repatha), a common PCSK9 inhibitor, can help patients with a history of percutaneous coronary intervention (PCI) lower their risk of a major cardiovascular event, according to new…
Distal radial (DR) access during percutaneous coronary intervention (PCI) is associated with lower rates of radial artery occlusion (RAO) than traditional radial (TR) access, according to a new meta-analysis in the American…
July typically marks the beginning of a new training cycle for academic medical centers, meaning fresh trainees with less experience are suddenly seeing patients and making important treatment decisions.
…
The U.S. Food and Drug Administration (FDA) made a lot of headlines in the last week, led by its approval of…
An international team of researchers has identified more than 150 genes commonly associated with coronary heart disease (CHD) and myocardial infarction…
There is a slightly elevated risk of intracranial thrombosis events following vaccination with the AstraZeneca ChAdOx1-S COVID-19 vaccine, according to two new studies publishing in PLOS Medicine.[1] Combined, these papers included more…
Ticagrelor monotherapy lowers the risk of bleeding events among high-risk percutaneous coronary intervention (PCI) patients with a history of myocardial infarction (MI), according to new findings published in JACC: Cardiovascular…
In recent years, more and more interventional procedures have been moved from conventional hospital-based cath labs to outpatient office-based labs (OBLs…
Polymer-free amphilimus-eluting stents (PF-AESs) are noninferior to drug-eluting stents (DESs) when treating coronary artery disease (CAD) patients with coronary revascularization, according to a new meta-analysis published in the…
Enhanced external counterpulsation (EECP) is associated with significant improvements in the health of long COVID patients with and without coronary artery disease (CAD), according to new data to be presented at the…